This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:w

rdf:type

rdac:C10001 bibo:Article

dcterms:isPartOf

n14:w

dcterms:subject

n7:degenerativejointdisease n7:musculoskeletalsyndromes n12:extendedreports n7:immunologyincludingallergy n7:rheumatoidarthritis n7:connectivetissuedisease

dcterms:title

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

rdaw:P10072

n11:web n11:print

vivo:relatedBy

n9:3 n9:17 n9:12 n9:6 n9:2 n9:4 n9:14 n9:10 n9:11 n9:15 n9:1 n9:18 n9:9 n9:19 n9:5 n9:7 n9:8 n9:13 n9:16

dcterms:abstract

Objective:. To conduct a cross-sectional review of non-selected consecutive outpatients with rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of the characteristics of patients with RA. Methods:. The review included current disease activity using data from clinical assessment and a patient self-report questionnaire, which was translated into each language. Data on demographic, disease and treatment-related variables were collected and analysed using descriptive statistics. Variation in disease activity on DAS28 (disease activity score on 28-joint count) within and between countries was graphically analysed. A median regression model was applied to analyse differences in disease activity between countries. Results:. Between January 2005 and October 2006, the QUEST-RA (Quantitative Patient Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis) project included 4363 patients from 48 sites in 15 countries; 78% were female, >90% Caucasian, mean age was 57 years and mean disease duration was 11.5 years. More than 80% of patients had been treated with methotrexate in all but three countries. Overall, patients had an active disease with a median DAS28 of 4.0, with a significant variation between countries (p<0.001). Among 42 sites with >50 patients included, low disease activity of DAS28 ⩽3.2 was found in the majority of patients in seven sites in five countries; in eight sites in five other countries, >50% of patients had high disease activity of DAS28 >5.1. Conclusions:. This international multicentre cross-sectional database provides an overview of clinical status and treatments of patients with RA in standard clinical care in 2005-6 including countries that are infrequently involved in clinical research projects.

hub:articleType

n6:researcharticle

hub:publisher-id

ar69252

dcterms:alternative

QUEST-RA in 15 countries

hub:isPartOfThisJournal

n15:w

bibo:pmid

17412740